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Abstract 
Benign metastasizing leiomyomas (BML) represent a rare phenomenon consisting of the extra-
uterine spread of smooth muscle cells with similar histological, immunological, and molecular 
patterns to those of benign uterine leiomyomas. They are considered benign based off their 
low mitotic activity, lack of anaplasia or necrosis, and limited vascularization. This condition 
represents an interesting diagnostic and treatment challenge based on their rarity and indolent 
nature. Our case represents a unique finding of BML in the thoracic spine in a postmenopausal 
woman many years after hysterectomy and partial oophorectomy. There are currently no 
standard guidelines for treatment of BML, given the rare nature of this condition, with most 
patients treated with a combination of surgical resection and radiotherapy, followed by hor-
monal treatment and radiological surveillance serving as the primary backbone of current 
management plans. Given that these patients present a unique clinical challenge in terms of 
diagnosis and management, it is important to delineate and further examine these rare entities. 
 © 2019 The Author(s) 
 Published by S. Karger AG, Basel 
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Introduction 
Benign metastasizing leiomyomas (BML) represent a rare phenomenon consisting of the 
extra-uterine spread of smooth muscle cells with similar histological, immunological, and mo-
lecular patterns to those of benign uterine leiomyomas. They are considered benign based off 
their low mitotic activity, lack of anaplasia or necrosis, and limited vascularization [1]. BML 
were first described in 1939 by Steiner [2]. BML most often occur in the lung, presenting as 
asymptomatic pulmonary nodules, however they can also be present in the cardiovascular 
system, lymph nodes, omentum, nervous system and retro-peritoneum and rarely in the spine 
[3]. The majority of women diagnosed with BML are premenopausal, however a small per-
centage are found in menopausal or postmenopausal women [4]. The majority of menopausal 
or postmenopausal cases occur in women who underwent hysterectomy for leiomyomas and 
were subsequently found to have metastases many years later [5, 6]. Multiple theories exist 
regarding the mechanism of BML although no clear consensus currently exists. One theory 
involves coelomic metaplasia and spread of the tumors to locations such as the cardiovascular 
system, peritoneum, and pleura. Another theory involves lymphovascular spread of the leio-
myoma cells and hormonal stimulation of local smooth muscle cells [7, 8]. Histologically, BML 
lesions are well-differentiated spindle cells without atypia or tumor necrosis, with a low pro-
liferative state which differentiate it from leiomyosarcomas. There are currently no guidelines 
for the treatment of BML and treatment is currently focused on surgical resection of the le-
sions in addition to hormonal and radiotherapy as an individualized approach. 
Case Presentation 
Mrs. Z is a 49-year-old Latina female with a history of HTN, and TAH with left oophorec-
tomy for adenomyosis in 2002, who was diagnosed with metastatic epithelioid leiomyoma 
involving the spine, lungs, and possibly adrenal gland. She initially presented with 2 months 
of progressively worsening bilateral lower extremity numbness and weakness in April 2015. 
MRI of her spine (Fig. 1) showed a T6/T7 mass, measuring 3.8 × 3.0 cm, with epidural com-
pression and bilateral pulmonary nodules, which were further confirmed with CT. The patient 
then underwent laminectomy and decompression of T5–T8 with pathology consistent with 
epithelioid leiomyoma composed of spindle cells of smooth muscle origin arranged in fascicles 
and small clusters. Additionally, there was no obvious cellular atypia or necrosis with a mitotic 
average of 0–2 per high-power field. Immuno-staining confirmed the cells to be of smooth 
muscle origin (SMA and Desmin positive) and showed that they were also ER (35%) and PR 
(95%) positive. CT guided lung biopsy confirmed metastatic leiomyoma. The patient’s estra-
diol level was checked and was found to be elevated at a premenopausal level of 50 which was 
abnormal given her previous history of total abdominal hysterectomy and left oophorectomy. 
The patient was started on Depo Lupron and Arimidex given her elevated estradiol level and 
ER positive and PR positive pathology. Additionally, she received radiotherapy to the spine in 
June 2015. Follow up PET CT in July, showed low FDG avid with similar target disease in the 
lung and T7 spine and possibly in the adrenal gland. The patient was continued on Arimidex. 
Follow up MRI and CT’s initially showed decreasing disease however eventually showed new 
spinal metastases in June 2016. The patient then underwent right oophorectomy a month 
later, to minimize endogenous hormonal exposure. Pathology of her right ovary was benign. 
Follow up CT in May 2017 showed the metastatic leiomyoma with stable metastatic disease 
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involving the lung parenchyma (Fig. 2, 3) and the thoracic spine with no new suspicious nod-
ules. 
Discussion 
Benign metastasizing leiomyomas are rare tumors composed of benign smooth muscle 
cells derived from uterine leiomyomas presenting in an extrauterine site. They are most often 
encountered in premenopausal women with a known history of leiomyomas [2, 8]. Many 
women diagnosed with BML have a history of uterine leiomyoma resection or hysterectomy 
making the diagnoses challenging in patients post hysterectomy [9]. Our patient presents a 
unique case in that her records indicated that her previous hysterectomy was due to adeno-
myosis and not leiomyoma, although it is possible however that she had leiomyomas at the 
time of hysterectomy and was misdiagnosed at the time. 
The mean age of women at the time of primary surgery is 38.5 years, and at the time of 
BML diagnosis is 47.3 years. Most common site of involvement are the lungs, lymph nodes, 
abdomen/pelvis, nervous system and bone. Spine metastases are rare and have only been re-
ported in a handful of case reports over the years. 
BML have characteristic immune-histochemical markers for muscle (SMA and Desmin) in 
addition to being estrogen and progesterone positive which is atypical for extrauterine 
smooth muscle tumors [2, 10]. Immuno-histochemical analysis is required for accurate diag-
nosis. Additionally, BML exhibit the same clonal pattern and genomic markers of uterine leio-
myomas [11]. These tumors most often metastasize to the lungs and have been only very 
rarely reported in the spine [3, 12]. We present a unique case involving a postmenopausal 
women with BML metastatic to the thoracic spine and lungs, and literature search reveals 
there are only limited case reports involving BML to the spine [3, 12, 13]. These patients pre-
sent a unique clinical challenge as spine BML requires a high level of suspicion and can be 
challenging to diagnose. Symptoms may vary from pain to weakness and radiculopathy as 
seen in our patient. Spine BML have typical MRI findings of a well circumscribed mass without 
any bony destruction or invasion and low T1 and T2 signal intensity with strong homogenous 
enhancement [3]. Understanding these characteristic findings can enable faster and more ac-
curate diagnosis. 
There are currently no guidelines for treatment of BML, given how rare the condition is, 
and most treatment is based on location and disease burden [2, 5]. BML are indolent in nature 
and treatment can involve targeted hormonal therapies and surgery [2]. Spine BML present 
even more of a treatment challenge as they are so rare and current reports offer no consensus 
for treatment. Surgical resection and radiotherapy are often the best option. Hormonal treat-
ment for BML using hormonal suppression has been found to result in disease regression or 
control in up to 79% of patients, however postmenopausal patients tend to have poorer out-
comes [2]. Even with hormonal treatment and surgical castration postmenopausal patients 
have been known to have disease progression [6]. This is demonstrated in our patient who 
after treatment with hormonal therapy eventually showed disease progression. At this point 
it was decided to proceed with right oophorectomy to decrease hormonal exposure. As BML 
are an indolent disease long term radiological surveillance is required with either CT or MRI 
to monitor for disease progression [5]. 
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Conclusions 
In conclusion, BML is a condition that presents an interesting diagnostic and treatment 
challenge based on their rarity and indolent nature. Our case represents a unique finding of 
BML in the thoracic spine in a postmenopausal woman many years after hysterectomy and 
partial oophorectomy. There are currently no standard guidelines for treatment of BML, given 
the rare nature of this condition, with most patients treated with a combination of surgical 
resection and radiotherapy, followed by hormonal treatment and radiological surveillance 
serving as the primary backbone of current management plans. Given that these patients pre-
sent a unique clinical challenge in terms of diagnosis and management, it is important to de-
lineate and further examine these rare entities. 
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Fig. 1. T-spine imaging with spine metastases. 
 
 
 
Fig. 2. Stable scattered less than 4 mm micronodules, left upper lobe. 
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Fig. 3. Stable perifissural mass in the right middle lobe. 
 
